ACAD
33.35
+1.39
+4.35%
AEMD
0.24
+0.03
+11.89%
APRI
1.92
+0.01
+0.52%
ARNA
4.48
+0.15
+3.46%
ATEC
1.41
+0.01
+0.71%
CNAT
7.53
-0.22
-2.84%
CRXM
0.195
0.00
0.00%
CYTX
1.2
+0.01
+0.84%
DXCM
61.98
+1.82
+3.03%
GNMK
13.3
+0.01
+0.08%
HALO
14
+0.07
+0.50%
ILMN
187.62
+0.45
+0.24%
INNV
0.179
+0.049
+37.5096%
INO
8.33
+0.05
+0.54%
ISCO
0.059
-0.003
-4.0984%
ISIS
64.81
+1.44
+2.27%
LGND
76.23
+3.28
+4.50%
LPTN
2.47
-0.01
-0.40%
MBVX
1.86
+0.24
+14.81%
MEIP
1.75
+0.01
+0.57%
MNOV
3.59
+0.04
+1.13%
MRTX
29.11
+0.69
+2.43%
MSTX
0.498
-0.002
-0.3006%
NBIX
41.53
+2.75
+7.09%
NUVA
46.4
+1.8
+4.04%
ONCS
0.35
0.00
0.00%
ONVO
3.37
-0.29
-7.92%
OREX
7.75
+0.21
+2.79%
OTIC
35.63
+1.4
+4.09%
QDEL
27.5
+0.35
+1.29%
RCPT
160.05
+12.62
+8.56%
RGLS
17.26
+0.44
+2.62%
RMD
71.65
+0.1
+0.14%
SCIE
0.026
-0.006
-17.7419%
SPHS
0.55
-0.04
-6.76%
SRNE
11.36
-0.93
-7.57%
TROV
7
0.00
0.00%
VICL
0.9
-0.02
-2.46%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
+0.03
+2.24%
ACAD
33.35
+1.39
+4.35%
AEMD
0.24
+0.03
+11.89%
APRI
1.92
+0.01
+0.52%
ARNA
4.48
+0.15
+3.46%
ATEC
1.41
+0.01
+0.71%
CNAT
7.53
-0.22
-2.84%
CRXM
0.195
0.00
0.00%
CYTX
1.2
+0.01
+0.84%
DXCM
61.98
+1.82
+3.03%
GNMK
13.3
+0.01
+0.08%
HALO
14
+0.07
+0.50%
ILMN
187.62
+0.45
+0.24%
INNV
0.179
+0.049
+37.5096%
INO
8.33
+0.05
+0.54%
ISCO
0.059
-0.003
-4.0984%
ISIS
64.81
+1.44
+2.27%
LGND
76.23
+3.28
+4.50%
LPTN
2.47
-0.01
-0.40%
MBVX
1.86
+0.24
+14.81%
MEIP
1.75
+0.01
+0.57%
MNOV
3.59
+0.04
+1.13%
MRTX
29.11
+0.69
+2.43%
MSTX
0.498
-0.002
-0.3006%
NBIX
41.53
+2.75
+7.09%
NUVA
46.4
+1.8
+4.04%
ONCS
0.35
0.00
0.00%
ONVO
3.37
-0.29
-7.92%
OREX
7.75
+0.21
+2.79%
OTIC
35.63
+1.4
+4.09%
QDEL
27.5
+0.35
+1.29%
RCPT
160.05
+12.62
+8.56%
RGLS
17.26
+0.44
+2.62%
RMD
71.65
+0.1
+0.14%
SCIE
0.026
-0.006
-17.7419%
SPHS
0.55
-0.04
-6.76%
SRNE
11.36
-0.93
-7.57%
TROV
7
0.00
0.00%
VICL
0.9
-0.02
-2.46%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
+0.03
+2.24%
Home » Archive by Category

Xconomy

Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M

January 28, 2015 – 5:00 am

It’s the moment of truth for any emerging diagnostics firm: the transition from startup to commercial-stage company. Time to convince insurers that you have something worth paying for, and doctors in…

[[Click headline to continue reading.]]

Aspyrian Therapeutics Raises $8.5M for New Tumor Immunotherapy

January 26, 2015 – 11:25 pm

San Diego-based Aspyrian Therapeutics, founded in 2010 to advance technology that uses near-infrared light to activate an immune response targeting certain types of tumors, has raised almost $8.5…

[[Click headline to continue reading.]]

Aspyrian Therapeutics Raises $8.5M for New Tumor Immunotherapy

January 26, 2015 – 11:25 pm

[Updated 2/4/15 12:15 pm. See below.] See below.San Diego-based Aspyrian Therapeutics, founded in 2010 to advance technology that uses near-infrared light to activate an immune response targeting…

[[Click headline to continue reading.]]

Aspyrian Therapeutics Raises $8.5M for New Tumor Immunotherapy

January 26, 2015 – 11:25 pm

[Updated 2/4/15 12:15 pm. See below.] See below.San Diego-based Aspyrian Therapeutics, founded in 2010 to advance technology that uses near-infrared light to activate an immune response targeting…

[[Click headline to continue reading.]]

Aspyrian Therapeutics Raises $8.5M for New Tumor Immunotherapy

January 26, 2015 – 11:25 pm

[Updated 2/4/15 12:15 pm. See below.] See below.San Diego-based Aspyrian Therapeutics, founded in 2010 to advance technology that uses near-infrared light to activate an immune response targeting…

[[Click headline to continue reading.]]

Innovation Outlook for 2015: Tackling Big Data Variety

January 26, 2015 – 9:16 am

In 2015, look for the innovation community to be talking about Big Data Variety: the problem, how to fix it, how to make money off of it. Companies have invested roughly $3-4 trillion on enterprise…

[[Click headline to continue reading.]]

Innovation Outlook for 2015: Tackling Big Data Variety

January 26, 2015 – 9:16 am

In 2015, look for the innovation community to be talking about Big Data Variety: the problem, how to fix it, how to make money off of it. Companies have invested roughly $3-4 trillion on enterprise…

[[Click headline to continue reading.]]

Innovation Outlook for 2015: Tackling Big Data Variety

January 26, 2015 – 9:16 am

In 2015, look for the innovation community to be talking about Big Data Variety: the problem, how to fix it, how to make money off of it. Companies have invested roughly $3-4 trillion on enterprise…

[[Click headline to continue reading.]]

From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs

January 26, 2015 – 1:30 am

Two weeks ago, in a sixth-floor room in San Francisco’s Four Seasons Hotel overlooking Market Street, Tony Coles, Susan Lindquist, and Kenneth Rhodes met with one financier after another in a…

[[Click headline to continue reading.]]

From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs

January 26, 2015 – 1:30 am

Two weeks ago, in a sixth-floor room in San Francisco’s Four Seasons Hotel overlooking Market Street, Tony Coles, Susan Lindquist, and Kenneth Rhodes met with one financier after another in a…

[[Click headline to continue reading.]]